DHL Group has announced a €2 billion investment in its newly established DHL Health Logistics brand, focusing on enhancing logistics capabilities in the life sciences and healthcare sectors. The initiative aims to ensure the efficient delivery of pharmaceuticals and biological products, covering multi-temperature transportation, cold chain facilities, and IT systems to achieve end-to-end visibility.
Ireland has released a biopharmaceutical tariff adjustment plan aimed at reducing R&D and compliance costs, and strengthening its global competitiveness. The new policy focuses on tax reductions for R&D equipment, adaptation to new EU regulations, incentives for high-value drug exports, and restrictions on low-value-added product exports. This move aims to address challenges such as the impact of new EU regulations and increased global competition. It is expected to promote the quality and efficiency of Ireland's biopharmaceutical industry, optimize the global trade landscape, and inject new impetus into Sino-Irish and EU-Irish pharmaceutical trade.
Haier Biomedical's HB TempCon reefer container has launched international routes, entering the global market and providing secure transportation for biopharmaceutical products, leading the industry's development. This expansion ensures temperature-sensitive biological materials are safely transported across borders, meeting the growing demand for reliable cold chain logistics in the biopharmaceutical sector. The move signifies Haier Biomedical's commitment to innovation and its ambition to become a key player in the global temperature-controlled transportation market.
UPS expands its International Special Commodities (ISC) program, adding over 50 international destinations to meet the biopharmaceutical industry's growing demand for cold chain logistics. The program supports the transport of biologics, dangerous goods, and commodities requiring dry ice refrigeration, adhering strictly to international regulations and providing contingency plans for safe and efficient global transportation. This expansion enhances UPS's ability to handle temperature-sensitive shipments, ensuring product integrity and compliance throughout the supply chain for the biomedical sector.
